bell
The current prices are delayed by 15 mins, login to check live prices.
Advanced Enzyme Technologies Ltd share price logo

Advanced Enzyme Technologies Ltd

(ADVENZYMES)

₹374.151.06%

as on 04:01PM, 02 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Advanced Enzyme Technologies Ltd Analyst Rating

based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts offering long term price targets for Advanced Enzyme Technologies Ltd. An average target of ₹470

Source: S&P Global Market Intelligence

Advanced Enzyme Technologies Ltd Share analysis

Advanced Enzyme Technologies Ltd price forecast by 1 analysts

Upside of24.29%

High

₹470

Target

₹470.00

Low

₹470

Advanced Enzyme Technologies Ltd target price ₹470, a slight upside of 24.29% compared to current price of ₹374.15. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Advanced Enzyme Technologies Ltd Performance

  • Day's Low

    Day's High

    ₹365.4
    ₹377.65
  • 52 Week's Low

    52 Week's High

    ₹324.65
    ₹571
1 Month Return-20.8 %
3 Month Return-13.53 %
1 Year Return+ 15.34 %
Previous Close₹378.15
Open₹370.00
Volume2.78L
Upper Circuit-
Lower Circuit-
Market Cap₹4,230.77Cr

Advanced Enzyme Technologies Ltd Key Statistics

P/E Ratio30.84
PEG Ratio28.04
Market Cap₹4,230.77 Cr
P/B Ratio6.69
EPS12.25
Dividend Yield1.47
SectorPharmaceuticals
ROE22.29

Advanced Enzyme Technologies Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
HOLD₹4,230.77 Cr25.45%0.50₹136 Cr₹623 Cr
NA₹268.78 Cr222.61%0.73NANA
NA₹161.71 Cr-2.06%0.64₹9 Cr₹131 Cr
NA₹438.04 Cr90.35%0.60₹5 Cr₹173 Cr
NA₹542.38 Cr-3.63%0.54NANA

About Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Limited AETL is the largest Indian enzyme company and is engaged in research, development, manufacturing and marketing of over 400 proprietary products developed from over 68 indigenous enzymes and probiotics. With state-of-the-art facilities in India, Germany and USA, it has transitioned the business and transformed the sector. AETL, formerly Advanced Biochemicals Limited, was established in 1989. In 2011, the company acquired CalIndia Foods International and in 2012 it acquired Advanced Supplementary Technologies Corporation. In 2016, the company came up with an Initial Public Offer (IPO) of 4594875 Equity shares of Rs 10 each which were subscribed 82.06 times. During the financial year ended 31 March 2017, AETL acquired 1.43 crore equity shares at Rs. 35 per share of JC Biotech Private Limited (JCB) and further acquired 200,000 equity shares and 150000 equity shares of MYR 1 of AEM. On July 11 2017, AETL incorporated a wholly owned subsidiary Advanced Enzymes Europe BV. On 3 October 2017, the company acquired certain assets and liabilities of Biomedic Labs and in January 2021 it completed 'the acquisition of controlling stake of 51 in SciTech Specialities Private Limited SSPL India'. On 29 May 2021 it acquired additional 15% stake of JCB. Overall on 31 March 2021, the company had 12 subsidiaries.

Share Price: ₹374.15 per share as on 02 Dec, 2024 04:01 PM
Market Capitalisation: ₹4,230.77Cr as of today
Revenue: ₹146.10Cr as on September 2024 (Q3 24)
Net Profit: ₹33.39Cr as on September 2024 (Q3 24)
Listing date: 01 Aug, 2016
Chairperson Name: VASANT RATHI
OrganisationAdvanced Enzyme Technologies Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Advanced Enzyme Technologies Ltd

  • Advanced Enzyme Technologies Faces Significant Stock Decline - 11 Nov, 2024

    Advanced Enzyme Technologies Ltd experienced a substantial decline in stock price, dropping over 13% after reporting disappointing Q2 FY25 results, including a 5% decrease in net profit and a 7% revenue drop. The company's EBITDA also fell by 17%, indicating weak operational performance across various segments.
  • Advanced Enzyme Technologies Reports Q2 FY25 Decline - 09 Nov, 2024

    In Q2 FY25, Advanced Enzyme Technologies reported a 7.4% year-over-year decline in revenue to ₹146.1 crore and a 5.1% drop in net profit to ₹33.4 crore.
  • StoxBox Optimistic on Advanced Enzyme Technologies - 30 Oct, 2024

    StoxBox sets a target price of Rs 533 for Advanced Enzyme Technologies Ltd, highlighting a buying range of Rs 444-450 with a 19% upside potential. The company is well-positioned in the growing global enzyme and probiotic markets.

Insights on Advanced Enzyme Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 12.03% to 12.63% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, PCBL Ltd has given 58.1% return, outperforming this stock by 42.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, PCBL Ltd has given 276.7% return, outperforming this stock by 260.6%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 43.02% to 42.95% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 36.87% to 36.41% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ADVENZYMES stock has moved down by -20.8%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 5.82% to 5.57% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 175.33 Cr → 155.71 Cr (in ₹), with an average decrease of 3.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 34.15 Cr → 32.83 Cr (in ₹), with an average decrease of 3.9% per quarter

Advanced Enzyme Technologies Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹157.84Cr (-)₹160.94Cr (↑1.96%)₹157.82Cr (↓1.94%)₹154.52Cr (↓2.09%)₹146.10Cr (↓5.45%)
Net Income₹35.20Cr (-)₹42.50Cr (↑20.74%)₹29.87Cr (↓29.72%)₹34.98Cr (↑17.11%)₹33.39Cr (↓4.55%)
Net Profit Margin22.30% (-)26.41% (↑18.43%)18.93% (↓28.32%)22.64% (↑19.60%)22.85% (↑0.93%)
Value in ₹ crore
Details2021202220232024
Total Assets₹490.70Cr (-)₹530.74Cr (↑8.16%)₹576.92Cr (↑8.70%)₹634.30Cr (↑9.95%)
Total Liabilities₹55.25Cr (-)₹50.39Cr (↓8.80%)₹51.58Cr (↑2.36%)₹53.82Cr (↑4.34%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹45.98Cr (-)₹84.23Cr (↑83.19%)₹37.10Cr (↓55.95%)₹50.30Cr (↑35.58%)₹55.81Cr (↑10.95%)

Index Inclusions

BSE Small-Cap

₹55,662.71

0.84 (462.85%)

BSE Healthcare

₹44,195.99

1.21 (530.48%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Advanced Enzyme Technologies Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
42.95%
-0.16
Foreign Institutions
12.63%
4.99
Mutual Funds
5.57%
-4.32
Retail Investors
36.41%
-1.27
Others
2.46%
8.32

Advanced Enzyme Technologies Ltd Key Indicators

Details20202021202220232024
Return On Equity %16.817.6211.911.0422.29
Details20202021202220232024
Return On Assets %30.3229.7422.5318.3121.02
Details20202021202220232024
Book Value Per Share (₹)75.1886.997.37110.45118.41
Details20202021202220232024
Earning Per Share (₹)11.9113.5411.079.2912.25

Advanced Enzyme Technologies Ltd Valuation

Advanced Enzyme Technologies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.53x)

March 23, 2020

Today (30.84x)

November 29, 2024

Industry (55.31x)

November 29, 2024

Highest (44.35x)

September 16, 2024

LowHigh

Advanced Enzyme Technologies Ltd Earnings and Dividends

  • Advanced Enzyme Technologies Ltd Earnings Results

    Advanced Enzyme Technologies Ltd’s net profit fell -4.59% since last year same period to ₹32.83Cr in the Q2 2024-2025. On a quarterly growth basis, Advanced Enzyme Technologies Ltd has generated -3.87% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Advanced Enzyme Technologies Ltd Dividends May,2024

    In the quarter ending March 2024, Advanced Enzyme Technologies Ltd has declared dividend of ₹1.10 - translating a dividend yield of 2.67%.

    Read More about Dividends

Advanced Enzyme Technologies Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Advanced Enzyme Technologies Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Advanced Enzyme Technologies Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Advanced Enzyme Technologies Ltd shares.

Advanced Enzyme Technologies Ltd (ADVENZYMES) share price today is ₹374.15

Advanced Enzyme Technologies Ltd is listed on NSE

Advanced Enzyme Technologies Ltd is listed on BSE

  • Today’s highest price of Advanced Enzyme Technologies Ltd is ₹377.65.
  • Today’s lowest price of Advanced Enzyme Technologies Ltd is ₹365.4.

PE Ratio of Advanced Enzyme Technologies Ltd is 30.84

PE ratio = Advanced Enzyme Technologies Ltd Market price per share / Advanced Enzyme Technologies Ltd Earnings per share

Today’s traded volume of Advanced Enzyme Technologies Ltd(ADVENZYMES) is 2.78L.

Today’s market capitalisation of Advanced Enzyme Technologies Ltd(ADVENZYMES) is ₹4230.77Cr.

Advanced Enzyme Technologies Ltd(ADVENZYMESPrice
52 Week High
₹571
52 Week Low
₹324.65

Advanced Enzyme Technologies Ltd(ADVENZYMES) share price is ₹374.15. It is down -34.47% from its 52 Week High price of ₹571

Advanced Enzyme Technologies Ltd(ADVENZYMES) share price is ₹374.15. It is up 15.25% from its 52 Week Low price of ₹324.65

Advanced Enzyme Technologies Ltd(ADVENZYMESReturns
1 Day Returns
-4%
1 Month Returns
-20.8%
3 Month Returns
-13.53%
1 Year Returns
15.34%